Sandoz, the generic drugs business that will be spun off its parent Novartis https://www.reuters.com/companies/NOVN.S” target=”_blank” rel=”noopener”>(NOVN.S), will boost investment in its European antibiotics production network by 50 million euros ($50 million…
Read More